PRESS RELEASE: IVI to Hold Second Methods Summit to Drive Patient-Centered Value Assessment
Summit Will Address Priority Patient Inputs for Comparative Effectiveness Research and HTA Alexandria, VA — April 27, 2021 — The Innovation and Value Initiative (IVI), an independent nonprofit research organization dedicated to advancing patient-centric value assessment, today announced it will convene the second annual Methods Summit, a multi-stakeholder event to drive consensus on priority patient […]
Getting Value Right
IVI’s Jennifer Bright and Rick Chapman recently published a commentary in STAT describing the urgency of getting value assessment right. Read the full commentary below. It’s time to get health care value assessment right By Jennifer Bright and Richard H. Chapman, April 15, 2021 Trying to gauge the value of new drugs and devices is […]
PRESS RELEASE: IVI Launches Groundbreaking Project Allowing Patients, Payers and Providers to Measure Value in Health Care
IVI’s “Open-Source Value Project” Develops Dynamic and Flexible Models to Help All Health Care Stakeholders Make Scientifically-Based Decisions about the Value of Treatments and Services; First Model, Released Today, is Focused on Rheumatoid Arthritis Treatments Los Angeles, CA (November 8, 2017) – The Innovation and Value Initiative (IVI) – a collaboration of academics, patient advocacy […]
PRESS RELEASE: IVI Names Veteran Health Care Strategist Jennifer Bright as New Acting Executive Director
Bright Brings Decades of Health Care Experience and Established Relationships to IVI Los Angeles, CA – March 5, 2018 – The Innovation and Value Initiative (IVI) – a collaboration dedicated to developing better approaches to measuring value in health care – today announced that Jennifer Bright (pictured left), founder and President of Momentum Health Strategies, […]
PRESS RELEASE: IVI Responds to ICER’s New Pilot Program
The Institute for Clinical Economic Review (ICER) recently launched a new pilot program that will allow more extensive evaluation of draft economic models used in ICER’s reports. In response to ICER’s new program, Mark Linthicum, Director of Scientific Communications for the Innovation and Value Initiative (IVI), commented: “The Innovation and Value Initiative (IVI) is working diligently […]
PRESS RELEASE: IVI’s Open-Source Value Project Produces Actionable Data on Value of Rheumatology Treatment Sequencing Designs
Washington, D.C. — June 14, 2018 — Measuring value in healthcare, which traditionally takes the perspective of a single payer managing population health and costs, needs to evolve to include diverse perspectives and provide relevant and actionable information on value to healthcare decision makers, according to a new article published today in the Journal of […]
PRESS RELEASE: Why IVI’s Next Open-Source Modeling Platform Will Focus on Value in Lung Cancer
Los Angeles, CA — June 20, 2018 — Oncology is both an area of immense clinical need and a primary driver of healthcare spending. As a result, cancer care is a focus of extensive debate around value. In short, the field of oncology offers a unique opportunity to develop patient-centered, robust, and flexible models for […]
PRESS RELEASE: IVI Responds to HHS’ Blueprint Saying Lowering Healthcare Costs Requires Improving Value Assessment
IVI Says Moving Beyond Cost Effectiveness by Evaluating Treatments Based on Unique Patient Characteristics and Preferences is Imperative Los Angeles, CA – July 16, 2018 — If we are going to truly harness data to lower healthcare costs while accelerating and rewarding innovation that benefits patients, then defining and assessing value in healthcare must improve, […]
PRESS RELEASE: IVI Releases Public Feedback and Technical Expert Panel Recommendations for Open-Source Platform Model to Assess Outcomes and Value of Rheumatoid Arthritis Therapies
Priorities Emerged Which Will Shape Version 2.0 of IVI’s RA Model Los Angeles, CA – September 20, 2018 — The Innovation and Value Initiative (IVI) today released public feedback and recommendations from its Technical Expert Panel (TEP), an objective third party comprised of five leaders in health economics, epidemiology, rheumatology, and patient communities, which the […]
PRESS RELEASE: IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment
IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment at Xtelligent Media’s Value Based Summit 2018 Boston, MA –- October 18, 2018 — Value Assessment 2.0 requires building assessment models that account for all of the factors that determine value instead of focusing only on cost and clinical benefits, said the executive director […]